Company · CC
The Chemours Company
Name as listed on its exchange; filed with the SEC as Chemours Co.
Nasdaq's symbol directory lists CC on the New York Stock Exchange as “Chemours Company (The) Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 7 occasions ($489K); 3 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Cowan Alister bought $203K
- CRANSTON MARY B bought $95K
- Denise Dignam, Chief Executive Officer bought $51K
- HOSTETTER SHANE, Chief Financial Officer bought $50K
- Familiar Calderon Gerardo, President, Advanced Performance Materials bought $30K
- Foley Michael Robert, President, Titanium Technologies bought $30K
- Martinko Joseph T., President, Thermal & Specialized Solutions bought $30K
Every trade (7)
- BUYFamiliar Calderon Gerardo, President, Advanced Performance Materials bought $30K
- BUYDenise Dignam, Chief Executive Officer bought $51K
- BUYCowan Alister bought $203K
- BUYCRANSTON MARY B bought $95K
- BUYFoley Michael Robert, President, Titanium Technologies bought $30K
- BUYMartinko Joseph T., President, Thermal & Specialized Solutions bought $30K
- BUYHOSTETTER SHANE, Chief Financial Officer bought $50K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 2, 2026
- Entry into a material definitive agreement; Regulation FD disclosure Sep 10, 2026
- Regulation FD disclosure Sep 9, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.